The
characterization of intestinal dissolution of poorly soluble drugs
represents a key task during the development of both new drug candidates
and drug products. The bicarbonate buffer is considered as the most
biorelevant buffer for simulating intestinal conditions. However,
because of its complex nature, being the volatility of CO2, it has only been rarely used in the past. The aim of this study
was to investigate the effect of a biorelevant bicarbonate buffer
on intestinal supersaturation and precipitation of poorly soluble
drugs using a gastrointestinal (GI) transfer model. Therefore, the
results of ketoconazole, pazopanib, and lapatinib transfer model experiments
using FaSSIFbicarbonate were compared with the results
obtained using standard FaSSIFphosphate. Additionally,
the effect of hydroxypropyl methylcellulose acetate succinate (HPMCAS)
as a precipitation inhibitor was investigated in both buffer systems
and compared to rat pharmacokinetic (PK) studies with and without
coadministration of HPMCAS as a precipitation inhibitor. While HPMCAS
was found to be an effective precipitation inhibitor for all drugs
in FaSSIFphosphate, the effect in FaSSIFbicarbonate was much less pronounced. The PK studies revealed that HPMCAS did
not increase the exposure of any of the model compounds significantly,
indicating that the transfer model employing bicarbonate-buffered
FaSSIF has a better predictive power compared to the model using phosphate-buffered
FaSSIF. Hence, the application of a bicarbonate buffer in a transfer
model set-up represents a promising approach to increase the predictive
power of this in vitrotool and to contribute to the development of
drug substances and drug products in a more biorelevant way.